ZNF430 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.490200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.762800E-01
Normal-vs-Stage2
4.507400E-01
Normal-vs-Stage3
2.740000E-01
Normal-vs-Stage4
6.853000E-01
Stage1-vs-Stage2
2.056800E-01
Stage1-vs-Stage3
5.249900E-02
Stage1-vs-Stage4
9.039800E-01
Stage2-vs-Stage3
1.757240E-01
Stage2-vs-Stage4
2.299800E-01
Stage3-vs-Stage4
4.853800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.463000E-01
Normal-vs-AfricanAmerican
5.356200E-01
Normal-vs-Asian
1.442560E-01
Caucasian-vs-AfricanAmerican
3.823400E-01
Caucasian-vs-Asian
3.427000E-01
AfricanAmerican-vs-Asian
3.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.752300E-02
Normal-vs-Female
4.437400E-01
Male-vs-Female
8.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.657800E-01
Normal-vs-Age(41-60Yrs)
5.377000E-01
Normal-vs-Age(61-80Yrs)
4.194000E-01
Normal-vs-Age(81-100Yrs)
7.362000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.427000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.631600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.295000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.139900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.081800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.876000E-01
Normal-vs-Daily Drinker
3.563600E-01
Normal-vs-Weekly Drinker
3.432200E-01
Normal-vs-Occasional Drinker
4.655200E-01
Normal-vs-Social Drinker
2.840400E-01
Non Drinker-vs-Daily Drinker
6.528400E-01
Non Drinker-vs-Weekly Drinker
5.513000E-01
Non Drinker-vs-Occasional Drinker
4.009000E-01
Non Drinker-vs-Social Drinker
2.167800E-01
Daily Drinker-vs-Weekly Drinker
8.599000E-01
Daily Drinker-vs-Occasional Drinker
2.393600E-01
Daily Drinker-vs-Social Drinker
1.400610E-01
Weekly Drinker-vs-Occasional Drinker
1.982000E-01
Weekly Drinker-vs-Social Drinker
1.323960E-01
Occasional Drinker-vs-Social Drinker
6.520400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.042000E-01
Normal-vs-Grade 2
7.862100E-02
Normal-vs-Grade 3
8.466300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.714200E-01
Grade 1-vs-Grade 3
6.675200E-01
Grade 1-vs-Grade 4
2.042000E-01
Grade 2-vs-Grade 3
9.257000E-01
Grade 2-vs-Grade 4
7.862100E-02
Grade 3-vs-Grade 4
8.466300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.139600E-01
Normal-vs-NonDiabetic
4.138000E-01
Diabetic-vs-NonDiabetic
9.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.180400E-01
Normal-vs-NoPancreatitis
4.302400E-01
Pancreatitis-vs-NoPancreatitis
1.556430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.250190E-01
Normal-vs-N1
4.560400E-01
N0-vs-N1
8.495600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.393200E-01
Normal-vs-TP53-NonMutant
2.113600E-01
TP53-Mutant-vs-TP53-NonMutant
4.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
